FDA Approved: DARZALEX FASPRO — Original Application (Janssen Biotech, Inc.)

View source ↗

Summary

FDA approves DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) under an original application for treatment of adults with multiple myeloma, introducing a sub…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT))

Snippet

ORIG AP for DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT))